QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
QQQ   348.82 (-1.70%)
AAPL   177.82 (-0.78%)
MSFT   323.38 (-3.09%)
META   263.60 (-2.77%)
GOOGL   122.50 (-3.78%)
AMZN   121.23 (-4.25%)
TSLA   224.57 (+1.47%)
NVDA   374.75 (-3.05%)
NIO   7.76 (-1.52%)
BABA   85.29 (-1.63%)
AMD   117.83 (-5.15%)
T   16.09 (+2.68%)
F   13.59 (+5.11%)
MU   67.06 (-0.71%)
CGC   0.72 (-2.69%)
GE   106.08 (+0.59%)
DIS   92.53 (+0.40%)
AMC   4.73 (+1.94%)
PFE   38.89 (+1.36%)
PYPL   64.04 (-1.51%)
NFLX   399.77 (+0.12%)
NASDAQ:OSUR

OraSure Technologies (OSUR) Stock Forecast, Price & News

$5.50
+0.01 (+0.18%)
(As of 06/7/2023 ET)
Compare
Today's Range
$5.45
$5.58
50-Day Range
$4.88
$7.39
52-Week Range
$2.62
$7.82
Volume
503,600 shs
Average Volume
593,948 shs
Market Capitalization
$402.93 million
P/E Ratio
14.10
Dividend Yield
N/A
Price Target
$5.00

OraSure Technologies MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
9.1% Downside
$5.00 Price Target
Short Interest
Healthy
2.12% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.09
Upright™ Environmental Score
News Sentiment
0.94mentions of OraSure Technologies in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From $0.25 to ($0.26) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.41 out of 5 stars

Medical Sector

918th out of 981 stocks

Surgical & Medical Instruments Industry

91st out of 97 stocks


OSUR stock logo

About OraSure Technologies (NASDAQ:OSUR) Stock

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.

Receive OSUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OraSure Technologies and its competitors with MarketBeat's FREE daily newsletter.

OSUR Stock News Headlines

Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Q1 2023 OraSure Technologies Inc Earnings Call
Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
OraSure Technologies (NASDAQ:OSUR) Stock Price Down 3.6%
3 Low-Beta Stocks to Buy to Combat the Volatile Market
Why OraSure Technologies Stock Is Jumping Today
See More Headlines

OSUR Price History

OSUR Company Calendar

Last Earnings
2/14/2023
Today
6/07/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:OSUR
CUSIP
68554V10
Employees
785
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.00
High Stock Price Forecast
$5.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
-9.1%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-17,930,000.00
Pretax Margin
5.59%

Debt

Sales & Book Value

Annual Sales
$387.48 million
Book Value
$5.01 per share

Miscellaneous

Free Float
71,650,000
Market Cap
$402.93 million
Optionable
Optionable
Beta
0.09

Key Executives

  • Carrie Eglinton Manner
    President, Chief Executive Officer & Director
  • Zachary Wert
    Senior Vice President-Global Operations
  • Kenneth McGrath
    Chief Financial Officer
  • Rafal Iwasiow
    Vice President, Science-Innovation & Technology
  • Michele Anthony
    Chief Accounting Officer, SVP & Controller













OSUR Stock - Frequently Asked Questions

What is OraSure Technologies' stock price forecast for 2023?

0 brokers have issued 12 month price objectives for OraSure Technologies' shares. Their OSUR share price forecasts range from $5.00 to $5.00. On average, they expect the company's share price to reach $5.00 in the next year. This suggests that the stock has a possible downside of 9.1%.
View analysts price targets for OSUR
or view top-rated stocks among Wall Street analysts.

How have OSUR shares performed in 2023?

OraSure Technologies' stock was trading at $4.82 at the beginning of the year. Since then, OSUR stock has increased by 14.1% and is now trading at $5.50.
View the best growth stocks for 2023 here
.

When is OraSure Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our OSUR earnings forecast
.

How were OraSure Technologies' earnings last quarter?

OraSure Technologies, Inc. (NASDAQ:OSUR) issued its earnings results on Tuesday, February, 14th. The medical instruments supplier reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.21. The medical instruments supplier had revenue of $123.08 million for the quarter, compared to analyst estimates of $96.88 million. OraSure Technologies had a trailing twelve-month return on equity of 12.66% and a net margin of 6.16%. The company's quarterly revenue was up 93.6% compared to the same quarter last year. During the same quarter last year, the business posted ($0.14) EPS.

What guidance has OraSure Technologies issued on next quarter's earnings?

OraSure Technologies updated its second quarter 2023 earnings guidance on Friday, May, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $62.00 million-$67.00 million, compared to the consensus revenue estimate of $96.67 million.

What is Stephen Tang's approval rating as OraSure Technologies' CEO?

2 employees have rated OraSure Technologies Chief Executive Officer Stephen Tang on Glassdoor.com. Stephen Tang has an approval rating of 100% among the company's employees. This puts Stephen Tang in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OraSure Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), Energy Transfer (ET), XOMA (XOMA), Overstock.com (OSTK), Ford Motor (F), Pfizer (PFE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

What is OraSure Technologies' stock symbol?

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

Who are OraSure Technologies' major shareholders?

OraSure Technologies' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (17.62%), State Street Corp (4.11%), Dimensional Fund Advisors LP (3.64%), American Capital Management Inc. (3.03%), Renaissance Technologies LLC (2.07%) and Geode Capital Management LLC (1.92%). Insiders that own company stock include Michael Celano, Nancy J Gagliano and Ronny B Lancaster.
View institutional ownership trends
.

How do I buy shares of OraSure Technologies?

Shares of OSUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OraSure Technologies' stock price today?

One share of OSUR stock can currently be purchased for approximately $5.50.

How much money does OraSure Technologies make?

OraSure Technologies (NASDAQ:OSUR) has a market capitalization of $402.93 million and generates $387.48 million in revenue each year. The medical instruments supplier earns $-17,930,000.00 in net income (profit) each year or $0.39 on an earnings per share basis.

How many employees does OraSure Technologies have?

The company employs 785 workers across the globe.

How can I contact OraSure Technologies?

OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The official website for the company is www.orasure.com. The medical instruments supplier can be reached via phone at (610) 882-1820, via email at investorinfo@orasure.com, or via fax at 610-882-1830.

This page (NASDAQ:OSUR) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -